Because the current optimal treatment for either ICNV or AMD is anti-VEGF agents [31, 32], it is important to check the existence of MNV by multimodal imaging and differentiate non-neovascular lesions with HRM from ICNV or AMD. The gene discussed is VEGFA; the disease is age-related macular degeneration.